New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron.

Karen Y Oróstica, Sebastian Contreras, Anamaria Sanchez-Daza, Jorge Fernandez, Viola Priesemann, Álvaro Olivera-Nappa

Author Information

Karen Y Oróstica: Sub Department of Molecular Genetics, Institute of Public Health of Chile (ISP), Santiago, Chile.
Sebastian Contreras: Max Planck Institute for Dynamics and Self-Organization, Am Faßberg 17, Göttingen DE-37077, Germany.
Anamaria Sanchez-Daza: Centre for Biotechnology and Bioengineering, Universidad de Chile, Chile.
Jorge Fernandez: Sub Department of Molecular Genetics, Institute of Public Health of Chile (ISP), Santiago, Chile.
Viola Priesemann: Max Planck Institute for Dynamics and Self-Organization, Am Faßberg 17, Göttingen DE-37077, Germany.
Álvaro Olivera-Nappa: Centre for Biotechnology and Bioengineering, Universidad de Chile, Chile.

PMID: 35187522 DOI: 10.1016/j.lana.2022.100203

No abstract text available.

Clin Infect Dis. 2021 Dec 16;: [PMID: 34915551]
Nature. 2022 Feb;602(7898):654-656 [PMID: 35016196]
BMJ. 2021 Dec 9;375:n3051 [PMID: 34887256]
Nat Hum Behav. 2021 Jul;5(7):947-953 [PMID: 33972767]
Nature. 2022 Jan 7;: [PMID: 35042229]
PLoS Comput Biol. 2021 Sep 2;17(9):e1009288 [PMID: 34473693]

Journal Article

Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant.Omicron - The new SARS-CoV-2 challenge?Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA.Omicron variant of SARS-CoV-2 - A new kid on the block.Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy.Development of New SNP Genotyping Assays to Discriminate the Omicron Variant of SARS-CoV-2.New SARS-CoV-2 Variant from Jordan.Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant.Across-the-board review on Omicron SARS-CoV-2 variant.SARS-CoV-2 During Omicron Variant Predominance Among Infants Born to People With SARS-CoV-2.

Describing a landscape we are yet discovering.The vaccine hesitancy continuum among hesitant adopters of the COVID-19 vaccine.Early mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants in Chile.The role of machine learning in health policies during the COVID-19 pandemic and in long COVID management.